Growth Equity Opportunities Fund, LLC's Net Worth
$3.22 Million
Who is Growth Equity Opportunities Fund, LLC?
Growth Equity Opportunities Fund, LLC has an estimated net worth of $3.22 Million. This is based on reported shares across multiple companies, which include SUNESIS PHARMACEUTICALS INC, and ARYx Therapeutics, Inc..
SEC CIK
Growth Equity Opportunities Fund, LLC's CIK is 0001448784
Past Insider Trading and Trends
2009 was Growth Equity Opportunities Fund, LLC's most active year for acquiring shares with 2 total transactions. Growth Equity Opportunities Fund, LLC's most active month to acquire stocks was the month of May. 2014 was Growth Equity Opportunities Fund, LLC's most active year for disposing of shares, totalling 5 transactions. Growth Equity Opportunities Fund, LLC's most active month to dispose stocks was the month of July. 2010 saw Growth Equity Opportunities Fund, LLC paying a total of $6,551,724.03 for 33,819,441 shares, this is the most they've acquired in one year. In 2014 Growth Equity Opportunities Fund, LLC cashed out on 977,240 shares for a total of $6,835,484.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.5601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.41% | -266.70K |
$7.97 | -$2,126,726.84 | 4.66M |
Aug 27 - Aug 29
| |||
Form 4
| -12.61% | -710.54K |
$6.63 | -$4,708,757.48 | 4.93M |
Aug 8 - Aug 12
| |||
Form 4
|
∞
| 33.82M |
$0.28 |
—
| 33.82M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.47M |
$0.07 | -$326,257.00 |
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||